RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
34.47
0.00 (-0.01%)
At close: Dec 5, 2025, 4:00 PM EST
33.82
-0.65 (-1.87%)
After-hours: Dec 5, 2025, 6:43 PM EST
RAPT Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -105.64 | -129.87 | -116.8 | -83.84 | -69.2 | -52.89 | |
| Depreciation & Amortization | 0.97 | 1.2 | 1.22 | 1.05 | 1 | 1.12 | |
| Loss (Gain) From Sale of Investments | -2.8 | -2.81 | -5.74 | -0.3 | 1.27 | 0.5 | |
| Stock-Based Compensation | 18.8 | 19.94 | 17.09 | 11.26 | 9.95 | 8.69 | |
| Other Operating Activities | 2.23 | 2.34 | 1.68 | 2.39 | 0.26 | -0.25 | |
| Change in Accounts Payable | 3.33 | -8.46 | 7.34 | 3.71 | 0.93 | 2.39 | |
| Change in Unearned Revenue | - | - | - | -1.53 | -3.43 | 0.96 | |
| Change in Other Net Operating Assets | -3.48 | 34.37 | -1.84 | -3.52 | -1.8 | -1.01 | |
| Operating Cash Flow | -86.58 | -83.3 | -97.05 | -70.77 | -61.03 | -40.49 | |
| Capital Expenditures | -0.08 | -0.12 | -1.13 | -0.85 | -0.76 | -0.4 | |
| Investment in Securities | -56.62 | 52.82 | 105.26 | -44.65 | -80.59 | -87.04 | |
| Investing Cash Flow | -56.7 | 52.7 | 104.13 | -45.49 | -81.35 | -87.44 | |
| Issuance of Common Stock | 143.31 | 152.85 | 1.45 | 131.18 | 141.48 | 75.46 | |
| Financing Cash Flow | 143.31 | 152.85 | 1.45 | 131.18 | 141.48 | 75.46 | |
| Net Cash Flow | 0.03 | 122.26 | 8.53 | 14.92 | -0.89 | -52.47 | |
| Free Cash Flow | -86.66 | -83.42 | -98.17 | -71.62 | -61.78 | -40.89 | |
| Free Cash Flow Margin | - | - | - | -4689.98% | -1620.27% | -810.97% | |
| Free Cash Flow Per Share | -4.00 | -16.37 | -20.49 | -17.61 | -18.05 | -13.55 | |
| Cash Income Tax Paid | - | - | - | - | - | 0.99 | |
| Levered Free Cash Flow | -46.39 | -38.77 | -54.19 | -40 | -34.44 | -22.33 | |
| Unlevered Free Cash Flow | -46.39 | -38.77 | -54.19 | -40 | -34.44 | -22.33 | |
| Change in Working Capital | -0.15 | 25.91 | 5.5 | -1.34 | -4.3 | 2.34 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.